Medtronic (NYSE:MDT) has received FDA 510(k) clearance for its Nellcor pulse oximetry system with the Nell-EQ intelligent ...
As the aging population continues to grow – projected to be more than 20% of the U.S. by 2030 – remote patient monitoring is becoming an increasingly important healthcare option. A recent industry ...
The Portrait Mobile system’s around-the-clock readings are meant to be an upgrade to traditional in-hospital monitoring methods, which typically check on patients’ vital signs only once every few ...
VANCOUVER, BC, Sept. 11, 2024 /PRNewswire/ - iData Research, a leading global consulting and market research firm, has released new, in-depth reports on the U.S. and European patient monitoring ...
Current solutions for remote health monitoring can be seen as invasive by patients and mostly do single variant intermittent tracking. FDA clearance brings one of Europe’s most advanced real-time ...
June 8, 2026 /3BL/ – Medtronic, a global leader in healthcare technology, announced FDA 510(k) clearance of its Nellcor™ pulse oximetry system with Nell-EQ™ intelligent processor. The Nell-EQ™ ...
(MENAFN- 3BL) June 8, 2026 /3BL/ - Medtronic, a global leader in healthcare technology, announced FDA 510(k) clearance of its NellcorTM pulse oximetry system with Nell-EQTM intelligent processor. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results